MDT

Medtronic
D

MDT

Arincen70/100B

Medtronic operating income 1986–2027

Medtronic's operating income in Q1 FY2027, the three months to 31 July 2026, was 1.76B USD, up 22.1% on the same quarter a year before. Medtronic's operating income over the last twelve months was 6.79B USD, up 10.8% on the twelve months before. In fiscal year 2026 it was 6.47B USD, up 8.6% on the year before.

Last updated 6 Nov 2026 · Next report 24 Nov 2026

Operating income

Operating income · +1.9% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM31 Jul 20266.79B+10.85%18.08%25.04B66.69%10.18B
FY202624 Apr 20266.47B+8.60%17.78%23.64B65.02%9.81B
FY202525 Apr 20255.96B+15.77%17.76%21.91B65.32%9.22B
FY202426 Apr 20245.14B-6.22%15.89%21.15B65.34%8.20B
FY202328 Apr 20235.49B-4.64%17.56%20.51B65.67%8.70B
FY202229 Apr 20225.75B+28.28%18.15%21.54B67.98%8.78B
FY202130 Apr 20214.48B-6.41%14.89%19.63B65.19%7.52B
FY202030 Apr 20204.79B-23.56%16.57%19.49B67.41%7.81B
FY201926 Apr 20196.27B-5.60%20.51%21.40B70.04%9.30B
FY201827 Apr 20186.64B+23.35%22.17%20.89B69.73%9.47B
FY201728 Apr 20175.38B+0.41%18.12%20.42B68.72%8.61B
FY201629 Apr 20165.36B+42.35%18.59%19.69B68.29%8.54B
FY201530 Apr 20153.77B-1.23%18.59%13.95B68.86%5.46B
FY201425 Apr 20143.81B-13.38%22.42%12.67B74.52%4.93B
FY201330 Apr 20134.40B-1.81%26.53%12.46B75.13%5.46B
FY201230 Apr 20124.48B+0.52%27.70%12.30B75.97%5.33B
FY201130 Apr 20114.46B-6.83%27.99%11.81B74.11%4.92B
FY201030 Apr 20104.79B+38.19%30.26%11.81B74.67%5.12B
FY200930 Apr 20093.46B-5.12%23.73%11.08B75.90%3.51B
FY200830 Apr 20083.65B-2.35%27.01%10.07B74.50%3.78B
FY200730 Apr 20073.74B+0.92%30.40%9.13B74.24%4.32B
FY200630 Apr 20063.71B+7.58%32.81%8.48B75.07%4.25B
FY200530 Apr 20053.44B+8.25%34.25%7.61B75.68%3.91B
FY200430 Apr 20043.18B+19.89%35.01%6.83B75.21%3.62B
FY200330 Apr 20032.65B+23.48%34.62%5.77B75.34%3.06B
FY200230 Apr 20022.15B+14.41%33.52%4.76B74.22%2.48B
FY200130 Apr 20011.88B+11.58%33.83%4.44B79.95%2.18B
FY200030 Apr 20001.68B+23.75%33.57%3.99B79.66%1.93B
FY199930 Apr 19991.36B+24.61%32.91%3.35B80.94%1.58B
FY199830 Apr 19981.09B+19.47%41.91%2.68B102.99%1.26B
FY199730 Apr 1997913.80M+43.68%37.48%2.32B94.96%1.05B
FY199630 Apr 1996636.00M+45.77%29.32%1.69B78.04%748.00M
FY199530 Apr 1995436.30M+31.18%25.04%1.31B75.11%542.80M
FY199430 Apr 1994332.60M+12.71%23.91%1.04B74.61%411.20M
FY199330 Apr 1993295.10M+19.96%22.22%977.70M73.61%364.70M
FY199230 Apr 1992246.00M+19.19%20.90%854.50M72.61%305.40M
FY199130 Apr 1991206.40M+25.09%20.21%736.20M72.08%252.90M
FY199030 Apr 1990165.00M+27.22%19.72%604.20M72.22%204.40M
FY198930 Apr 1989129.70M-0.31%17.49%547.30M73.79%174.30M
FY198830 Apr 1988130.10M+23.08%19.91%472.30M72.29%159.10M
FY198730 Apr 1987105.70M+38.53%21.06%359.20M71.55%132.10M
FY198630 Apr 198676.30M—18.94%285.30M70.83%99.60M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Medtronic's operating income

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.